A 48-year-old female patient with rheumatoid arthritis (on chronic corticosteroids) is undergoing elective hip arthroplasty. After induction with propofol and remifentanil, rocuronium 0.6 mg/kg IV is given for intubation. Intubation is achieved easily. At the end of surgery (120 minutes later), train-of-four (TOF) monitoring shows 2 out of 4 twitches. The anaesthetist plans to reverse the neuromuscular blockade. Which agent is most appropriate and why?

Question

Accepted Answer

A. Sugammadex 4 mg/kg IV, as rocuronium is a steroidal non-depolarising agent that is rapidly encapsulated and eliminated. ## Neuromuscular Blockade Reversal: Rocuronium and Sugammadex ### Mechanism of Rocuronium **Key Point:** Rocuronium is a **steroidal (aminosteroid) non-depolarising neuromuscular blocking agent** that binds competitively to nicotinic acetylcholine receptors at the neuromuscular junction. - **Onset:** 60–90 seconds - **Duration:** 30–40 minutes (intermediate-acting) - **Metabolism:** Hepatic and renal elimination; no Hofmann elimination - **Structure:** Steroidal nucleus with quaternary ammonium group ### Reversal Agents: Comparison | Agent | Mechanism | Onset | Duration | TOF Level | Efficacy | Notes | |-------|-----------|-------|----------|-----------|----------|-------| | **Sugammadex** | Encapsulation of rocuronium/vecuronium (cyclodextrin) | 1–3 min | 15–30 min | All levels (deep, moderate, shallow) | Excellent | **First-line for rocuronium** | | **Neostigmine** | Acetylcholinesterase inhibition (indirect reversal) | 7–11 min | 30–60 min | Shallow block only (TOF > 2) | Moderate | Muscarinic side effects; requires antimuscarinic | | **Edrophonium** | Acetylcholinesterase inhibition (faster than neostigmine) | 30–60 sec | 5–10 min | Shallow block only | Moderate | **Withdrawn in many countries** (cardiac arrhythmias) | **High-Yield:** Sugammadex is a **selective relaxant binding agent (SRBA)** — it encapsulates rocuronium and vecuronium molecules in a 1:1 ratio, forming inactive complexes that are rapidly excreted renally. ### Why Sugammadex for Rocuronium? ```mermaid flowchart TD A[Rocuronium administered]:::outcome --> B[Binds nicotinic receptors]:::outcome B --> C{Reversal needed}:::decision C -->|Shallow block
TOF > 2| D[Neostigmine + antimuscarinic]:::action C -->|Moderate/Deep block
TOF ≤ 2| E[Sugammadex ONLY option]:::action D --> F[Indirect reversal:
↑ ACh at NMJ]:::outcome E --> G[Direct encapsulation:
Rocuronium inactivated]:::outcome F --> H[Slower onset,
muscarinic effects]:::outcome G --> H2[Rapid onset,
no muscarinic effects]:::outcome ``` **Key Point:** With TOF = 2/4 (moderate blockade), **neostigmine is ineffective** because it cannot reverse deep or moderate blockade reliably. Sugammadex is the only agent that works at all blockade depths. ### Dosing of Sugammadex | Clinical Scenario | Dose | Timing | |-------------------|------|--------| | **Shallow blockade** (TOF ratio ≥ 0.9) | 1.2 mg/kg | Anytime | | **Moderate blockade** (TOF 1–2 twitches) | 2 mg/kg | Anytime | | **Deep blockade** (post-tetanic potentiation only) | 4 mg/kg | Anytime | | **Immediate reversal** (rocuronium 1.2 mg/kg given) | 16 mg/kg | Within 3 min | **Clinical Pearl:** In this case, TOF = 2/4 represents **moderate blockade**, requiring **2 mg/kg sugammadex** (approximately 96 mg for a 48 kg female). The question states 4 mg/kg, which is appropriate for deeper blockade or to ensure complete reversal. ### Why NOT Neostigmine at TOF 2/4? 1. **Inefficacy:** Neostigmine works only at shallow blockade (TOF > 2). At TOF = 2, it may fail to achieve adequate reversal. 2. **Muscarinic side effects:** Causes bronchospasm, bradycardia, salivation, miosis — requires antimuscarinic (glycopyrrolate or atropine). 3. **Slow onset:** 7–11 minutes vs. sugammadex 1–3 minutes. 4. **Recurarization risk:** Neostigmine has shorter duration than rocuronium; blockade may recur post-operatively. **Mnemonic — Sugammadex Advantage: FAST** — **F**ast onset, **A**ll blockade depths, **S**teroidal agent (rocuronium/vecuronium), **T**rue encapsulation (not enzymatic) ### Special Consideration: Rheumatoid Arthritis + Corticosteroids **Clinical Pearl:** Chronic corticosteroid use may impair neuromuscular function and increase sensitivity to neuromuscular blockers. This patient may have prolonged blockade, making rapid sugammadex reversal especially valuable. [cite:Miller's Anesthesia 9e Ch 40; Stoelting's Pharmacology in Anesthesia 5e Ch 12]

Answer

B. Neostigmine 5 mg IV with glycopyrrolate, as it is effective at all levels of blockade

Answer

C. Edrophonium 1 mg/kg IV, as it has faster onset than neostigmine and is preferred for rocuronium reversal

Answer

D. Atropine 0.5 mg IV alone, as it prevents muscarinic side effects of reversal agents

Explanation

Practice similar questions